Otmar D. Wiestler
Director/Board Member at BAYER AG
Profile
Otmar D.
Wiestler is currently the Chairman at Technische Universität München, the Director at Mark Foundation, an Independent Member-Supervisory Board at Bayer AG, and the President at Helmholtz-Gemeinschaft Deutscher Forschungszentren eV.
Previously, he served as the Chairman-Management Board & Scientific Director at German Cancer Research Center, the Medical Director at Life & Brain GmbH, and a Professor at the University of Bonn.
He obtained his doctorate degree from the University of Freiburg in 1984.
Otmar D. Wiestler active positions
Companies | Position | Start |
---|---|---|
BAYER AG | Director/Board Member | 2014-10-08 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | President | 2015-08-31 |
Technische Universität München | Chairman | 2015-12-31 |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Director/Board Member | 2023-05-09 |
Former positions of Otmar D. Wiestler
Companies | Position | End |
---|---|---|
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Chief Executive Officer | 2014-12-31 |
University of Bonn | Corporate Officer/Principal | 2002-12-31 |
LIFE & BRAIN GmbH
LIFE & BRAIN GmbH Miscellaneous Commercial ServicesCommercial Services LIFE & BRAIN GmbH operates as a development-stage biomedical company. The firm develops novel strategies for the diagnosis and therapy of nervous system disorders. It offers its products and services in different business units: LIFE & BRIAN CellSolutions, Genomics, NeuroEconomics and Electrophysiology services. The company is headquartered in Bonn, Germany. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Training of Otmar D. Wiestler
University of Freiburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BAYER AG | Health Technology |
Private companies | 4 |
---|---|
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Commercial Services |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
LIFE & BRAIN GmbH
LIFE & BRAIN GmbH Miscellaneous Commercial ServicesCommercial Services LIFE & BRAIN GmbH operates as a development-stage biomedical company. The firm develops novel strategies for the diagnosis and therapy of nervous system disorders. It offers its products and services in different business units: LIFE & BRIAN CellSolutions, Genomics, NeuroEconomics and Electrophysiology services. The company is headquartered in Bonn, Germany. | Commercial Services |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Commercial Services |
- Stock Market
- Insiders
- Otmar D. Wiestler